STOCK TITAN

Shareholder plans CBLL (NASDAQ: CBLL) sale of 39,000 shares after recent trades

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

CBLL shareholder Xingjuan Chao has filed a Form 144 to sell 39,000 shares of common stock, with an aggregate market value of $799,890, through Fidelity Brokerage Services on NASDAQ around February 4, 2026. The notice shows these shares coming from stock option exercises dated April 30, 2018 and February 4, 2026.

Over the prior three months, the same shareholder reported CBLL common stock sales of 50,000 shares on November 21, 2025, 25,000 shares on December 1, 2025, 25,000 shares on December 4, 2025, and 79,000 shares on January 5, 2026, with disclosed gross proceeds for each transaction.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the CBLL Form 144 filing by Xingjuan Chao disclose?

The Form 144 filing discloses a planned sale of 39,000 CBLL common shares. The shares, valued at about $799,890, are to be sold through Fidelity Brokerage Services on NASDAQ around February 4, 2026, and originate from previously granted stock options.

How many CBLL shares does Xingjuan Chao plan to sell under this Form 144?

The filing states that 39,000 CBLL common shares are planned for sale. These shares have an aggregate market value of $799,890 and are to be sold through Fidelity Brokerage Services LLC on NASDAQ, with an approximate sale date of February 4, 2026.

What prior CBLL share sales by Xingjuan Chao are listed in the last three months?

The notice lists four prior CBLL common stock sales in three months. They include 50,000 shares on November 21, 2025, 25,000 on December 1, 2025, 25,000 on December 4, 2025, and 79,000 on January 5, 2026, each with stated gross proceeds.

How were the CBLL shares being sold under Form 144 originally acquired?

The filing shows the CBLL shares were acquired through stock option transactions. It lists a stock option exercise on April 30, 2018 for 14,000 shares and an option granted February 16, 2023, with 25,000 shares acquired on February 4, 2026, both paid in cash.

What is the reported market value of the CBLL shares in the planned Form 144 sale?

The 39,000 CBLL common shares have an aggregate market value of $799,890. This value is tied to the planned sale through Fidelity Brokerage Services LLC on NASDAQ, with the approximate transaction date indicated as February 4, 2026.

How many CBLL shares are reported as outstanding in the Form 144 filing?

The Form 144 lists 37,095,690 CBLL common shares outstanding. This figure appears in the securities information table alongside the 39,000 shares planned for sale and provides a baseline context for the company’s total common stock.
CeriBell, Inc.

NASDAQ:CBLL

CBLL Rankings

CBLL Latest News

CBLL Latest SEC Filings

CBLL Stock Data

717.43M
29.28M
10.43%
84.44%
3.61%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
SUNNYVALE